The biotechnology universe is divided into two groups.
The majority are companies without profits, or even sales, chasing a scientific breakthrough and the resulting massive payoff for investors. A much smaller group of companies have graduated to megacap status. Like most companies of their size, these sport massive profits and cash flows, with much less growth potential.
No, you are correct🧡
I guess that could happen))😀
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Sumber: WSJ - 🏆 98. / 63 Baca lebih lajut »